Source link : https://newshealth.biz/health-news/fda-clears-first-diagnostic-blood-test-for-ad/

The US Food and Drug Administration (FDA) has granted 510(k) clearance to the first blood test to aid in diagnosing Alzheimer’s disease (AD).  The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio, from Fujirebio Diagnostics, Inc., is for the early detection of amyloid plaques associated with AD in adults aged 55 years and older who show signs […]

The post FDA Clears First Diagnostic Blood Test for AD first appeared on News Health.

—-

Author : News Health

Publish date : 2025-05-16 19:48:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678